Personalised care planning gives better T2D control 

The drive towards personalised care continues with the development of new software called the Healum app. Results of an 18-month trial presented at the Diabetes UK professional conference in March showed people who used it had an average 9.5% reduction in HbA1c blood glucose compared with 2% reduction in a comparable control group. “A key challenge in long-term condition management is to motivate and support patients to make healthy choices and understand how to best manage their diabetes in a way that means something to them,” said Dr. Adrian Heald, a diabetes specialist from Salford Royal Hospital, who led the National Institute of Health Research-funded study in Manchester. The app has so far been trialled in just 36 volunteers and the aim is now to collect data from a further 214 people to see how it can best be adjusted and refined. 

The app has been developed by the co-founders of Healum, Anuj Saboo and Jonathan Abraham. They worked collaboratively with diabetes clinicians throughout the project, helping to inform the design of the product so it can work as a truly assistive technology to make doctors lives easier, and improve outcomes for patients.

First featured in Desang Diabetes magazine here.